EUVIMEDEUVIMED entdecken
Crossref

Tumor-derived CCL15 regulates RNA m6A methylation in cancer-associated fibroblasts to promote hepatocellular carcinoma growth

Chaomin Wang, Dong Dong, Na Zhao, Yang Liu, Changsen Bai, Jialei Hua, Ranliang Cui, Xi Wei, Ting Zhao, Ning Ji, Shuaini Yang, Jie Zhao und 2 weitere

Cancer Letters · 2025

DOI: 10.1016/j.canlet.2024.217420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Chaomin Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laborat…. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Liver Neoplasms, Carcinoma, Hepatocellular, Chemokines, CC. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is a lethal malignancy characterized by rapid growth. The interaction between tumor cells and cancer-associated fibroblasts (CAFs) significantly influences HCC progression. CCL15, a CC chemokine family member, is predominantly expressed in HCC and strongly correlates with tumor size, indicating its critical role in HCC growth. However, previous studies suggest that CCL15 does not directly stimulate cancer cell proliferation. The specific role and mechanism of CCL15 in HCC proliferation remain unknown. Here, we identified that CCL15 was predominantly overexpressed by HCC cells through single-cell RNA sequencing data and immunofluorescence. We discovered that CCL15 promotes HCC growth by stimulating the crosstalk between HCC cells and CAFs via CCR1 signaling, as evidenced by co-culture assays, organoid models, and allograft models. Mechanistically, CCL15 induced the expression of FTO in CAFs through the STAT3 pathway. By m6A sequencing and RNA sequencing, we found that CEBPA mRNA, a transcription factor regulating CXCL5 expression, was a target of FTO. CXCL5, secreted by CAFs, activated the CXCR2 receptor on HCC cells and enhanced their proliferation. Notably, we found that interfering with CCL15 signaling using a neutralizing antibody attenuated HCC growth in heterotypic co-injection and patient-derived xenograft murine models. Finally, CXCL5 also upregulated CCL15 expression in HCC cells by modulating P53 expression through MDM2, forming a positive feedback loop. Our study unveiled CCL15 as a key mediator in HCC progression, facilitating communication between HCC cells and CAFs. This highlights a novel regulatory axis in HCC and suggests that targeting CCL15 could be a potential therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer-Associated FibroblastsLiver NeoplasmsCarcinoma, HepatocellularChemokines, CCMacrophage Inflammatory ProteinsHumansAnimalsCell ProliferationRNA MethylationMiceGene Expression Regulation, NeoplasticCell Line, TumorSignal TransductionReceptors, CCR1Mice, NudeMaleEpitranscriptomeSTAT3 Transcription FactorAdenosine

Stichwörter der Autor:innen

C-C motif chemokine 15Liver cancerTumor-associated fibroblastsm(6)A modification

Substanzen

CCL15 protein, humanChemokines, CCMacrophage Inflammatory ProteinsReceptors, CCR1CCR1 protein, humanSTAT3 Transcription FactorN-methyladenosineAdenosine

Autor:innen und Institutionen

  • Department of Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Key Laboratory of Cancer Prevention and Thera…
  • Department of Hepatobiliary Cancer, Liver Cancer Center, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's C…
  • Department of Diagnostic and Therapeutic Ultrasonography, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin'…
  • Department of Immunology, School of Basic Medical Sciences, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Educational Ministry of China, Tianjin Medical University, Tianjin, 300070, PR C…
  • Department of Kidney Transplantation, Tianjin First Central Hospital, Tianjin, 300110, PR China. Electronic address: zjsecond@aliyun.com.

Zitieren

APA

Wang, C., Dong, D., Zhao, N., Liu, Y., Bai, C., Hua, J., Cui, R., Wei, X., Zhao, T., Ji, N., Yang, S., Zhao, J., Li, H., & Li, Y. (2025). Tumor-derived CCL15 regulates RNA m6A methylation in cancer-associated fibroblasts to promote hepatocellular carcinoma growth. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217420

Vancouver

Wang C, Dong D, Zhao N, Liu Y, Bai C, Hua J, et al. Tumor-derived CCL15 regulates RNA m6A methylation in cancer-associated fibroblasts to promote hepatocellular carcinoma growth. Cancer Letters. 2025. doi:10.1016/j.canlet.2024.217420

BibTeX
@article{Wang2025,
  author = {Wang, Chaomin and Dong, Dong and Zhao, Na and Liu, Yang and Bai, Changsen and Hua, Jialei and Cui, Ranliang and Wei, Xi and Zhao, Ting and Ji, Ning and Yang, Shuaini and Zhao, Jie and Li, Huikai and Li, Yueguo},
  title = {Tumor-derived CCL15 regulates RNA m6A methylation in cancer-associated fibroblasts to promote hepatocellular carcinoma growth},
  journal = {Cancer Letters},
  year = {2025},
  doi = {10.1016/j.canlet.2024.217420}
}
Kostenlos starten →